Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A: Comparison with B-Domain Deleted rFVIII, and Value of Potential Viral Transmission Reduction due to Plasma/Albumin-Free Status

Author： Sclar David A.   Evans Marc A.   Skaer Tracy L.   Robison Linda M.   Chung Karen C.   Poulios Nick S.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.6, Iss.3, 2005-01, pp. : 149-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®): A Review of its Use in the Management of Patients with Haemophilia A

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 987-1007

Adis International

Access to resources Recommend Favorite

Octocog alfa, Plasma/Albumin-Free Method

By McCormack Paul L.   Plosker Greg L.  

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2613-2620

Adis International

Access to resources Recommend Favorite

Octocog alfa, plasma/albumin-free method: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 6, 2006-06 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Octocog alfa, Plasma/Albumin-Free Method: A Viewpoint by Massimo Franchini

By Franchini Massimo  

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2621-2622

Adis International

Access to resources Recommend Favorite

Factor VIII – Baxter: rAHF-PFM, Recombinant Anti-Haemophilic Factor – Protein-Free Method, Recombinant Factor VIII – Protein-Free

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 366-368

Adis International

Access to resources Recommend Favorite